AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 153 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $30,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,854,631 | $97,384,000 | 7.25% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,267,382 | $125,724,000 | 5.06% |
| Healthcare Value Capital, LLC | 229,481 | $4,603,000 | 3.86% |
| Tamarack Capital Management, LLC | 943,526 | $18,352,000 | 3.75% |
| KING INVESTMENT ADVISORS INC/TX | 248,065 | $4,976,000 | 2.12% |
| TAMRO Capital Partners LLC | 1,889,738 | $37,908,000 | 1.92% |
| Healthcare Value Capital, LLC | 100,000 | $2,006,000 | 1.68% |
| Artal Group S.A. | 2,015,000 | $40,421,000 | 1.63% |
| Tiger Legatus Capital Management, LLC | 150,000 | $3,009,000 | 1.14% |
| DAVIDE LEONE & PARTNERS INVESTMENT Co LLP | 272,000 | $5,456,000 | 1.12% |